Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Health Research Projects

McGill University

$150,251.00

Multidimensional separation isolation and characterization of circulating tumour cells

FY 2014-15

Summary
BACKGROUND. If cancer remains localized, it can often be treated, but if it metastasis, it vecome very difficult. Metastasis isthought to occur by so-called circulating tumor cells, or CTCs. These CTCs are emerging as a new element for prognosis ofcancer, as well as for measuring the response to therapy, and to diagnose recurrence much earlier. The presence of as littleas 3-5 CTCs per 7.5 ml of blood may have prognostic significance, this volume also contains ~ 100,000,000 white bloodcells, rendering CTC isolation extremely challenging. In addition, CTCs are heterogeneous, and further it is important todifferentiate between dead and live cells with metastatic potential. Although separation systems exist, they typically isolatecells based on a single property, either mechanical or biomolecular, and have been shown to miss many cells.PROJECT: Here we propose to develop a low cost CTC isolation cartridge that will capture cells from 10 ml of blood in a fewminutes based on both mechanical and molecular characteristics. We thus hope to isolate a much greater variety of cells,and make CTCs a much more reliable diagnostic and prognostic tool. We believe that this will also help us understand whichcells are responsible for cancer metastasis, which may then lead to targeted therapies to eradicate them. The low cost of ourtechnology should also greatly accelerate the translation to the clinic and its adoption as a standard of care to help treatcancer patients.
Program
Collaborative Health Research Projects
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
446671-2013
Name nom
Juncker, David
Department département
Biomedical Engineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2013
Award amount
150251
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
2 & 3
Nb partie
3
Application title
Multidimensional separation isolation and characterization of circulating tumour cells
Keyword
NSERC
Application summary
BACKGROUND. If cancer remains localized, it can often be treated, but if it metastasis, it vecome very difficult. Metastasis isthought to occur by so-called circulating tumor cells, or CTCs. These CTCs are emerging as a new element for prognosis ofcancer, as well as for measuring the response to therapy, and to diagnose recurrence much earlier. The presence of as littleas 3-5 CTCs per 7.5 ml of blood may have prognostic significance, this volume also contains ~ 100,000,000 white bloodcells, rendering CTC isolation extremely challenging. In addition, CTCs are heterogeneous, and further it is important todifferentiate between dead and live cells with metastatic potential. Although separation systems exist, they typically isolatecells based on a single property, either mechanical or biomolecular, and have been shown to miss many cells.PROJECT: Here we propose to develop a low cost CTC isolation cartridge that will capture cells from 10 ml of blood in a fewminutes based on both mechanical and molecular characteristics. We thus hope to isolate a much greater variety of cells,and make CTCs a much more reliable diagnostic and prognostic tool. We believe that this will also help us understand whichcells are responsible for cancer metastasis, which may then lead to targeted therapies to eradicate them. The low cost of ourtechnology should also greatly accelerate the translation to the clinic and its adoption as a standard of care to help treatcancer patients.
McGill University - $150,251 Grant (2014-15) | Canada Spends